Zheng Cao Selected Research

Immune Checkpoint Inhibitors

2/2024	Activating CD8+ T Cells by Pt(IV) Prodrug-Based Nanomedicine and aPD-L1 Antibody for Enhanced Cancer Immunotherapy.
10/2023	Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy.
9/2022	Icariside I - A novel inhibitor of the kynurenine-AhR pathway with potential for cancer therapy by blocking tumor immune escape.
1/2022	KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Cao Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 02/2013
15	Inflammation (Inflammations) 03/2024 - 04/2014
9	Wounds and Injuries (Trauma) 03/2024 - 01/2020
8	Spinal Cord Injuries (Spinal Cord Injury) 05/2024 - 02/2015
7	Pain (Aches) 01/2023 - 11/2013
6	Infections 11/2023 - 01/2019
6	Pre-Eclampsia (Preeclampsia) 01/2023 - 12/2019
5	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2016
5	Intervertebral Disc Displacement (Herniated Disc) 07/2023 - 04/2016
5	Non-alcoholic Fatty Liver Disease 05/2023 - 06/2020
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 05/2009
4	Thrombosis (Thrombus) 12/2023 - 01/2008
4	Osteoporosis 09/2023 - 01/2016
4	Colitis 09/2023 - 10/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 07/2023 - 04/2016
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 11/2017
3	Carcinogenesis 01/2024 - 01/2015
3	Postmenopausal Osteoporosis 11/2023 - 01/2014
3	Adenocarcinoma of Lung 09/2023 - 01/2021
3	Hemolysis 11/2022 - 11/2002
3	Bone Diseases (Bone Disease) 07/2022 - 12/2015
3	Body Weight (Weight, Body) 07/2022 - 05/2016
3	Reperfusion Injury 01/2022 - 10/2017
3	Myocardial Infarction 07/2018 - 07/2006
3	Cysts 01/2016 - 10/2013
2	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2022
2	Melanoma (Melanoma, Malignant) 10/2023 - 08/2021
2	Atherosclerosis 10/2023 - 11/2022
2	Pregnancy Complications 09/2023 - 12/2021
2	Bone Resorption 02/2023 - 12/2020
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023 - 01/2021
2	Stroke (Strokes) 01/2023 - 10/2020
2	Weight Gain 11/2022 - 01/2019
2	Leukemia 10/2022 - 04/2016
2	Low Back Pain (Lumbago) 01/2022 - 06/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2009
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
8	EnzymesIBA 03/2024 - 01/2016
7	HydrogelsIBA 05/2024 - 01/2018
7	Messenger RNA (mRNA)IBA 11/2021 - 04/2016
7	AluminumIBA 12/2020 - 12/2015
4	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
4	LipidsIBA 01/2024 - 01/2021
4	AntibodiesIBA 09/2022 - 11/2002
4	Aluminum ChlorideIBA 07/2017 - 01/2016
3	CholesterolIBA 03/2024 - 05/2023
3	LigandsIBA 01/2024 - 02/2021
3	Cetuximab (Erbitux)FDA Link 01/2024 - 11/2017
3	AntioxidantsIBA 11/2023 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 12/2021
3	isoquercitrinIBA 11/2023 - 11/2022
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 01/2019
3	Hemostatics (Antihemorrhagics)IBA 10/2023 - 07/2021
3	oxidized low density lipoproteinIBA 10/2023 - 12/2021
3	FlavonoidsIBA 09/2023 - 11/2022
3	Bile Acids and Salts (Bile Acids)IBA 05/2023 - 04/2021
3	icariside IIBA 02/2023 - 08/2021
3	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2014
3	FibrinIBA 01/2022 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 07/2017
3	AndrogensIBA 01/2022 - 02/2016
3	LipopolysaccharidesIBA 11/2021 - 01/2020
3	OligosaccharidesIBA 04/2021 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 07/2020 - 07/2010
3	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 07/2020 - 04/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2017
2	triclocarbanIBA 03/2024 - 08/2023
2	Small Interfering RNA (siRNA)IBA 03/2024 - 01/2021
2	SilicatesIBA 02/2024 - 10/2023
2	CatalaseIBA 11/2023 - 10/2020
2	Glutathione (Reduced Glutathione)IBA 11/2023 - 07/2017
2	Oxidoreductases (Dehydrogenase)IBA 11/2023 - 01/2019
2	Superoxide DismutaseIBA 11/2023 - 07/2017
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2023 - 10/2020
2	empagliflozinIBA 10/2023 - 11/2022
2	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023 - 11/2022
2	Apolipoproteins E (ApoE)IBA 10/2023 - 11/2022
2	Estrogens (Estrogen)FDA Link 09/2023 - 02/2023
2	Dextran SulfateIBA 09/2023 - 08/2023
2	Volatile Fatty AcidsIBA 08/2023 - 08/2021
2	16S Ribosomal RNAIBA 08/2023 - 05/2023
2	T-2 Toxin (T 2 Toxin)IBA 02/2023 - 07/2022
2	Capsules (Microcapsules)IBA 01/2023 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2022 - 01/2021
2	Amino Acids FDA Link 06/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 10/2019

Therapy/Procedure

14	Therapeutics 02/2024 - 01/2016
10	Immunotherapy 02/2024 - 01/2021
4	Stents 01/2022 - 07/2006
3	Decompression 07/2023 - 04/2016
3	Diskectomy (Discectomy) 01/2023 - 01/2020
3	Percutaneous Coronary Intervention 01/2022 - 12/2008
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2015
2	Length of Stay 11/2023 - 03/2020
2	Ovariectomy (Oophorectomy) 11/2023 - 02/2023
2	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2023 - 03/2020
2	Oral Administration 09/2022 - 08/2021
2	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2022 - 01/2022